Literature DB >> 25662751

The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes.

Aleksandar D Kostic1, Dirk Gevers2, Heli Siljander3, Tommi Vatanen4, Tuulia Hyötyläinen5, Anu-Maaria Hämäläinen6, Aleksandr Peet7, Vallo Tillmann7, Päivi Pöhö8, Ismo Mattila5, Harri Lähdesmäki9, Eric A Franzosa10, Outi Vaarala11, Marcus de Goffau12, Hermie Harmsen12, Jorma Ilonen13, Suvi M Virtanen14, Clary B Clish2, Matej Orešič5, Curtis Huttenhower15, Mikael Knip16, Ramnik J Xavier17.   

Abstract

Colonization of the fetal and infant gut microbiome results in dynamic changes in diversity, which can impact disease susceptibility. To examine the relationship between human gut microbiome dynamics throughout infancy and type 1 diabetes (T1D), we examined a cohort of 33 infants genetically predisposed to T1D. Modeling trajectories of microbial abundances through infancy revealed a subset of microbial relationships shared across most subjects. Although strain composition of a given species was highly variable between individuals, it was stable within individuals throughout infancy. Metabolic composition and metabolic pathway abundance remained constant across time. A marked drop in alpha-diversity was observed in T1D progressors in the time window between seroconversion and T1D diagnosis, accompanied by spikes in inflammation-favoring organisms, gene functions, and serum and stool metabolites. This work identifies trends in the development of the human infant gut microbiome along with specific alterations that precede T1D onset and distinguish T1D progressors from nonprogressors.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25662751      PMCID: PMC4689191          DOI: 10.1016/j.chom.2015.01.001

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  53 in total

1.  Large procyanidins prevent bile-acid-induced oxidant production and membrane-initiated ERK1/2, p38, and Akt activation in Caco-2 cells.

Authors:  Mathieu Da Silva; Grayson K Jaggers; Sandra V Verstraeten; Alejandra G Erlejman; Cesar G Fraga; Patricia I Oteiza
Journal:  Free Radic Biol Med       Date:  2011-10-19       Impact factor: 7.376

2.  Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.

Authors:  Ju Young Chang; Dionysios A Antonopoulos; Apoorv Kalra; Adriano Tonelli; Walid T Khalife; Thomas M Schmidt; Vincent B Young
Journal:  J Infect Dis       Date:  2008-02-01       Impact factor: 5.226

3.  Incidence of type 1 diabetes in Finland.

Authors:  Valma Harjutsalo; Reijo Sund; Mikael Knip; Per-Henrik Groop
Journal:  JAMA       Date:  2013-07-24       Impact factor: 56.272

4.  Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns.

Authors:  Maria G Dominguez-Bello; Elizabeth K Costello; Monica Contreras; Magda Magris; Glida Hidalgo; Noah Fierer; Rob Knight
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

5.  The long-term stability of the human gut microbiota.

Authors:  Jeremiah J Faith; Janaki L Guruge; Mark Charbonneau; Sathish Subramanian; Henning Seedorf; Andrew L Goodman; Jose C Clemente; Rob Knight; Andrew C Heath; Rudolph L Leibel; Michael Rosenbaum; Jeffrey I Gordon
Journal:  Science       Date:  2013-07-05       Impact factor: 47.728

6.  Antibiotics in early life alter the murine colonic microbiome and adiposity.

Authors:  Ilseung Cho; Shingo Yamanishi; Laura Cox; Barbara A Methé; Jiri Zavadil; Kelvin Li; Zhan Gao; Douglas Mahana; Kartik Raju; Isabel Teitler; Huilin Li; Alexander V Alekseyenko; Martin J Blaser
Journal:  Nature       Date:  2012-08-30       Impact factor: 49.962

Review 7.  Lipid disorders in type 1 diabetes.

Authors:  B Vergès
Journal:  Diabetes Metab       Date:  2009-09-04       Impact factor: 6.041

8.  Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes.

Authors:  Christopher T Brown; Austin G Davis-Richardson; Adriana Giongo; Kelsey A Gano; David B Crabb; Nabanita Mukherjee; George Casella; Jennifer C Drew; Jorma Ilonen; Mikael Knip; Heikki Hyöty; Riitta Veijola; Tuula Simell; Olli Simell; Josef Neu; Clive H Wasserfall; Desmond Schatz; Mark A Atkinson; Eric W Triplett
Journal:  PLoS One       Date:  2011-10-17       Impact factor: 3.240

9.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

10.  Development of the human infant intestinal microbiota.

Authors:  Chana Palmer; Elisabeth M Bik; Daniel B DiGiulio; David A Relman; Patrick O Brown
Journal:  PLoS Biol       Date:  2007-06-26       Impact factor: 8.029

View more
  381 in total

Review 1.  Dysbiosis and the immune system.

Authors:  Maayan Levy; Aleksandra A Kolodziejczyk; Christoph A Thaiss; Eran Elinav
Journal:  Nat Rev Immunol       Date:  2017-03-06       Impact factor: 53.106

Review 2.  Blood-based signatures in type 1 diabetes.

Authors:  Susanne M Cabrera; Yi-Guang Chen; William A Hagopian; Martin J Hessner
Journal:  Diabetologia       Date:  2015-12-23       Impact factor: 10.122

3.  Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.

Authors:  Kirsty Brown; Artem Godovannyi; Caixia Ma; YiQun Zhang; Zahra Ahmadi-Vand; Chaunbin Dai; Monika A Gorzelak; YeeKwan Chan; Justin M Chan; Arion Lochner; Jan P Dutz; Bruce A Vallance; Deanna L Gibson
Journal:  ISME J       Date:  2015-08-14       Impact factor: 10.302

Review 4.  Impact of occupational exposure on human microbiota.

Authors:  Peggy S Lai; David C Christiani
Journal:  Curr Opin Allergy Clin Immunol       Date:  2019-04

Review 5.  Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics.

Authors:  Romain Banchereau; Alma-Martina Cepika; Jacques Banchereau; Virginia Pascual
Journal:  Annu Rev Immunol       Date:  2017-01-30       Impact factor: 28.527

6.  Development of a New Application for Comprehensive Viability Analysis Based on Microbiome Analysis by Next-Generation Sequencing: Insights into Staphylococcal Carriage in Human Nasal Cavities.

Authors:  Yu Jie Lu; Takashi Sasaki; Kyoko Kuwahara-Arai; Yuki Uehara; Keiichi Hiramatsu
Journal:  Appl Environ Microbiol       Date:  2018-05-17       Impact factor: 4.792

7.  Accounting for reciprocal host-microbiome interactions in experimental science.

Authors:  Thaddeus S Stappenbeck; Herbert W Virgin
Journal:  Nature       Date:  2016-06-09       Impact factor: 49.962

8.  Gut microbial metabolites alter IgA immunity in type 1 diabetes.

Authors:  Juan Huang; James A Pearson; Jian Peng; Youjia Hu; Sha Sha; Yanpeng Xing; Gan Huang; Xia Li; Fang Hu; Zhiguo Xie; Yang Xiao; Shuoming Luo; Chen Chao; F Susan Wong; Zhiguang Zhou; Li Wen
Journal:  JCI Insight       Date:  2020-05-21

Review 9.  The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis.

Authors:  James C Needell; Danny Zipris
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

10.  Association of HLA-dependent islet autoimmunity with systemic antibody responses to intestinal commensal bacteria in children.

Authors:  Alexandra Paun; Christopher Yau; Shahab Meshkibaf; Michelle C Daigneault; Leili Marandi; Steven Mortin-Toth; Amit Bar-Or; Emma Allen-Vercoe; Philippe Poussier; Jayne S Danska
Journal:  Sci Immunol       Date:  2019-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.